Description
6,6'-Dihydroxy-4,4,4',4',7,7'-hexamethyl-2,2'-spirobichroman is a highly potent and extensively studied compound within the biomedical industry. By demonstrating remarkable effectiveness against several malignancies including breast, ovarian, and prostate cancer, this compound has emerged as a promising breakthrough in cancer therapy. Notably, its distinctive molecular configuration endows it with extraordinary antioxidant attributes, thereby facilitating the mitigation of oxidative stress-related maladies. The distinctive and intricate chemical architecture of this compound prompts its potential employment as a valuable instrument for cutting-edge biomedicine researchers in their quest for novel therapeutic modalities.
Synonyms
7,7'-Dimethyl-6,6'-dihydroxy-4,4,4',4'-tetramethylbis-2,2'-spirochroman; 6,6'-DIHYDROXY-4,4,4',4',7,7'-HEXAMETHYL-2,2'-SPIROBICHROMAN; 6,6'-DIHYDROXY-4,4,4',4',7,7'-HEXAMETHYL-2,2'-SPIROBICHROMAN, 2-PROPANOL ADDUCT; 6,6'-DIHYDROXY-4,4,4',4',7,7'-HEXAMETHYL-
IUPAC Name
4,4,4',4',7,7'-hexamethyl-2,2'-spirobi[3H-chromene]-6,6'-diol
InChI
InChI=1S/C23H28O4/c1-13-7-19-15(9-17(13)24)21(3,4)11-23(26-19)12-22(5,6)16-10-18(25)14(2)8-20(16)27-23/h7-10,24-25H,11-12H2,1-6H3